Global Biosimilar Contract Manufacturing Market Growth (Status and Outlook) 2025-2031

February 2025 | 106 pages | ID: G80B597893CEEN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Biosimilar Contract Manufacturing Market Size (2020-2031)
  2.1.2 Biosimilar Contract Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Biosimilar Contract Manufacturing by Country/Region (2020, 2024 & 2031)
2.2 Biosimilar Contract Manufacturing Segment by Type
  2.2.1 Recombinant Non-glycosylated Proteins
  2.2.2 Recombinant Glycosylated Proteins
2.3 Biosimilar Contract Manufacturing Market Size by Type
  2.3.1 Biosimilar Contract Manufacturing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Biosimilar Contract Manufacturing Market Size Market Share by Type (2020-2025)
2.4 Biosimilar Contract Manufacturing Segment by Application
  2.4.1 Oncology
  2.4.2 Blood Disorders
  2.4.3 Growth Hormonal Deficiency
  2.4.4 Chronic & Autoimmune Disorders
  2.4.5 Rheumatoid Arthritis
  2.4.6 Others
2.5 Biosimilar Contract Manufacturing Market Size by Application
  2.5.1 Biosimilar Contract Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Biosimilar Contract Manufacturing Market Size Market Share by Application (2020-2025)

3 BIOSIMILAR CONTRACT MANUFACTURING MARKET SIZE BY PLAYER

3.1 Biosimilar Contract Manufacturing Market Size Market Share by Player
  3.1.1 Global Biosimilar Contract Manufacturing Revenue by Player (2020-2025)
  3.1.2 Global Biosimilar Contract Manufacturing Revenue Market Share by Player (2020-2025)
3.2 Global Biosimilar Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BIOSIMILAR CONTRACT MANUFACTURING BY REGION

4.1 Biosimilar Contract Manufacturing Market Size by Region (2020-2025)
4.2 Global Biosimilar Contract Manufacturing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Biosimilar Contract Manufacturing Market Size Growth (2020-2025)
4.4 APAC Biosimilar Contract Manufacturing Market Size Growth (2020-2025)
4.5 Europe Biosimilar Contract Manufacturing Market Size Growth (2020-2025)
4.6 Middle East & Africa Biosimilar Contract Manufacturing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Biosimilar Contract Manufacturing Market Size by Country (2020-2025)
5.2 Americas Biosimilar Contract Manufacturing Market Size by Type (2020-2025)
5.3 Americas Biosimilar Contract Manufacturing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Biosimilar Contract Manufacturing Market Size by Region (2020-2025)
6.2 APAC Biosimilar Contract Manufacturing Market Size by Type (2020-2025)
6.3 APAC Biosimilar Contract Manufacturing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Biosimilar Contract Manufacturing Market Size by Country (2020-2025)
7.2 Europe Biosimilar Contract Manufacturing Market Size by Type (2020-2025)
7.3 Europe Biosimilar Contract Manufacturing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Biosimilar Contract Manufacturing by Region (2020-2025)
8.2 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Type (2020-2025)
8.3 Middle East & Africa Biosimilar Contract Manufacturing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BIOSIMILAR CONTRACT MANUFACTURING MARKET FORECAST

10.1 Global Biosimilar Contract Manufacturing Forecast by Region (2026-2031)
  10.1.1 Global Biosimilar Contract Manufacturing Forecast by Region (2026-2031)
  10.1.2 Americas Biosimilar Contract Manufacturing Forecast
  10.1.3 APAC Biosimilar Contract Manufacturing Forecast
  10.1.4 Europe Biosimilar Contract Manufacturing Forecast
  10.1.5 Middle East & Africa Biosimilar Contract Manufacturing Forecast
10.2 Americas Biosimilar Contract Manufacturing Forecast by Country (2026-2031)
  10.2.1 United States Market Biosimilar Contract Manufacturing Forecast
  10.2.2 Canada Market Biosimilar Contract Manufacturing Forecast
  10.2.3 Mexico Market Biosimilar Contract Manufacturing Forecast
  10.2.4 Brazil Market Biosimilar Contract Manufacturing Forecast
10.3 APAC Biosimilar Contract Manufacturing Forecast by Region (2026-2031)
  10.3.1 China Biosimilar Contract Manufacturing Market Forecast
  10.3.2 Japan Market Biosimilar Contract Manufacturing Forecast
  10.3.3 Korea Market Biosimilar Contract Manufacturing Forecast
  10.3.4 Southeast Asia Market Biosimilar Contract Manufacturing Forecast
  10.3.5 India Market Biosimilar Contract Manufacturing Forecast
  10.3.6 Australia Market Biosimilar Contract Manufacturing Forecast
10.4 Europe Biosimilar Contract Manufacturing Forecast by Country (2026-2031)
  10.4.1 Germany Market Biosimilar Contract Manufacturing Forecast
  10.4.2 France Market Biosimilar Contract Manufacturing Forecast
  10.4.3 UK Market Biosimilar Contract Manufacturing Forecast
  10.4.4 Italy Market Biosimilar Contract Manufacturing Forecast
  10.4.5 Russia Market Biosimilar Contract Manufacturing Forecast
10.5 Middle East & Africa Biosimilar Contract Manufacturing Forecast by Region (2026-2031)
  10.5.1 Egypt Market Biosimilar Contract Manufacturing Forecast
  10.5.2 South Africa Market Biosimilar Contract Manufacturing Forecast
  10.5.3 Israel Market Biosimilar Contract Manufacturing Forecast
  10.5.4 Turkey Market Biosimilar Contract Manufacturing Forecast
10.6 Global Biosimilar Contract Manufacturing Forecast by Type (2026-2031)
10.7 Global Biosimilar Contract Manufacturing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Biosimilar Contract Manufacturing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Boehringer Ingelheim Biopharmaceuticals GmbH
  11.1.1 Boehringer Ingelheim Biopharmaceuticals GmbH Company Information
  11.1.2 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product Offered
  11.1.3 Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Boehringer Ingelheim Biopharmaceuticals GmbH Main Business Overview
  11.1.5 Boehringer Ingelheim Biopharmaceuticals GmbH Latest Developments
11.2 Lonza
  11.2.1 Lonza Company Information
  11.2.2 Lonza Biosimilar Contract Manufacturing Product Offered
  11.2.3 Lonza Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Lonza Main Business Overview
  11.2.5 Lonza Latest Developments
11.3 Catalent, Inc.
  11.3.1 Catalent, Inc. Company Information
  11.3.2 Catalent, Inc. Biosimilar Contract Manufacturing Product Offered
  11.3.3 Catalent, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Catalent, Inc. Main Business Overview
  11.3.5 Catalent, Inc. Latest Developments
11.4 Biocon
  11.4.1 Biocon Company Information
  11.4.2 Biocon Biosimilar Contract Manufacturing Product Offered
  11.4.3 Biocon Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Biocon Main Business Overview
  11.4.5 Biocon Latest Developments
11.5 IQVIA Inc.
  11.5.1 IQVIA Inc. Company Information
  11.5.2 IQVIA Inc. Biosimilar Contract Manufacturing Product Offered
  11.5.3 IQVIA Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 IQVIA Inc. Main Business Overview
  11.5.5 IQVIA Inc. Latest Developments
11.6 AGC Biologics
  11.6.1 AGC Biologics Company Information
  11.6.2 AGC Biologics Biosimilar Contract Manufacturing Product Offered
  11.6.3 AGC Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AGC Biologics Main Business Overview
  11.6.5 AGC Biologics Latest Developments
11.7 Samsung Biologics
  11.7.1 Samsung Biologics Company Information
  11.7.2 Samsung Biologics Biosimilar Contract Manufacturing Product Offered
  11.7.3 Samsung Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Samsung Biologics Main Business Overview
  11.7.5 Samsung Biologics Latest Developments
11.8 WuXi Biologics
  11.8.1 WuXi Biologics Company Information
  11.8.2 WuXi Biologics Biosimilar Contract Manufacturing Product Offered
  11.8.3 WuXi Biologics Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 WuXi Biologics Main Business Overview
  11.8.5 WuXi Biologics Latest Developments
11.9 Element Materials Technology
  11.9.1 Element Materials Technology Company Information
  11.9.2 Element Materials Technology Biosimilar Contract Manufacturing Product Offered
  11.9.3 Element Materials Technology Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Element Materials Technology Main Business Overview
  11.9.5 Element Materials Technology Latest Developments
11.10 Rentschler Biopharma SE
  11.10.1 Rentschler Biopharma SE Company Information
  11.10.2 Rentschler Biopharma SE Biosimilar Contract Manufacturing Product Offered
  11.10.3 Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Rentschler Biopharma SE Main Business Overview
  11.10.5 Rentschler Biopharma SE Latest Developments
11.11 Avid Bioservices, Inc.
  11.11.1 Avid Bioservices, Inc. Company Information
  11.11.2 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product Offered
  11.11.3 Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Avid Bioservices, Inc. Main Business Overview
  11.11.5 Avid Bioservices, Inc. Latest Developments
11.12 Alcami Corporation, Inc.
  11.12.1 Alcami Corporation, Inc. Company Information
  11.12.2 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product Offered
  11.12.3 Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Alcami Corporation, Inc. Main Business Overview
  11.12.5 Alcami Corporation, Inc. Latest Developments
11.13 Fujifilm Kyowa Kirin Biologics Co., Ltd.
  11.13.1 Fujifilm Kyowa Kirin Biologics Co., Ltd. Company Information
  11.13.2 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product Offered
  11.13.3 Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Fujifilm Kyowa Kirin Biologics Co., Ltd. Main Business Overview
  11.13.5 Fujifilm Kyowa Kirin Biologics Co., Ltd. Latest Developments
11.14 Thermo Fisher Scientific Inc.
  11.14.1 Thermo Fisher Scientific Inc. Company Information
  11.14.2 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Product Offered
  11.14.3 Thermo Fisher Scientific Inc. Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.14.5 Thermo Fisher Scientific Inc. Latest Developments
11.15 Almac Group
  11.15.1 Almac Group Company Information
  11.15.2 Almac Group Biosimilar Contract Manufacturing Product Offered
  11.15.3 Almac Group Biosimilar Contract Manufacturing Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Almac Group Main Business Overview
  11.15.5 Almac Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Biosimilar Contract Manufacturing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Biosimilar Contract Manufacturing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Non-glycosylated Proteins
Table 4. Major Players of Recombinant Glycosylated Proteins
Table 5. Biosimilar Contract Manufacturing Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Biosimilar Contract Manufacturing Market Size byType (2020-2025) & ($ millions)
Table 7. Global Biosimilar Contract Manufacturing Market Size Market Share byType (2020-2025)
Table 8. Biosimilar Contract Manufacturing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Biosimilar Contract Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Biosimilar Contract Manufacturing Market Size Market Share by Application (2020-2025)
Table 11. Global Biosimilar Contract Manufacturing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Biosimilar Contract Manufacturing Revenue Market Share by Player (2020-2025)
Table 13. Biosimilar Contract Manufacturing Key Players Head office and Products Offered
Table 14. Biosimilar Contract Manufacturing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biosimilar Contract Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Biosimilar Contract Manufacturing Market Size Market Share by Region (2020-2025)
Table 19. Global Biosimilar Contract Manufacturing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Biosimilar Contract Manufacturing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Biosimilar Contract Manufacturing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Biosimilar Contract Manufacturing Market Size Market Share by Country (2020-2025)
Table 23. Americas Biosimilar Contract Manufacturing Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Biosimilar Contract Manufacturing Market Size Market Share byType (2020-2025)
Table 25. Americas Biosimilar Contract Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Biosimilar Contract Manufacturing Market Size Market Share by Application (2020-2025)
Table 27. APAC Biosimilar Contract Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Biosimilar Contract Manufacturing Market Size Market Share by Region (2020-2025)
Table 29. APAC Biosimilar Contract Manufacturing Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Biosimilar Contract Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Biosimilar Contract Manufacturing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Biosimilar Contract Manufacturing Market Size Market Share by Country (2020-2025)
Table 33. Europe Biosimilar Contract Manufacturing Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Biosimilar Contract Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Biosimilar Contract Manufacturing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Biosimilar Contract Manufacturing Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Biosimilar Contract Manufacturing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Biosimilar Contract Manufacturing
Table 39. Key Market Challenges & Risks of Biosimilar Contract Manufacturing
Table 40. Key IndustryTrends of Biosimilar Contract Manufacturing
Table 41. Global Biosimilar Contract Manufacturing Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Biosimilar Contract Manufacturing Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Biosimilar Contract Manufacturing Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Biosimilar Contract Manufacturing Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Boehringer Ingelheim Biopharmaceuticals GmbH Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 46. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Product Offered
Table 47. Boehringer Ingelheim Biopharmaceuticals GmbH Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Boehringer Ingelheim Biopharmaceuticals GmbH Main Business
Table 49. Boehringer Ingelheim Biopharmaceuticals GmbH Latest Developments
Table 50. Lonza Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 51. Lonza Biosimilar Contract Manufacturing Product Offered
Table 52. Lonza Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Lonza Main Business
Table 54. Lonza Latest Developments
Table 55. Catalent, Inc. Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 56. Catalent, Inc. Biosimilar Contract Manufacturing Product Offered
Table 57. Catalent, Inc. Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Catalent, Inc. Main Business
Table 59. Catalent, Inc. Latest Developments
Table 60. Biocon Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 61. Biocon Biosimilar Contract Manufacturing Product Offered
Table 62. Biocon Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Biocon Main Business
Table 64. Biocon Latest Developments
Table 65. IQVIA Inc. Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 66. IQVIA Inc. Biosimilar Contract Manufacturing Product Offered
Table 67. IQVIA Inc. Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. IQVIA Inc. Main Business
Table 69. IQVIA Inc. Latest Developments
Table 70. AGC Biologics Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 71. AGC Biologics Biosimilar Contract Manufacturing Product Offered
Table 72. AGC Biologics Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. AGC Biologics Main Business
Table 74. AGC Biologics Latest Developments
Table 75. Samsung Biologics Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 76. Samsung Biologics Biosimilar Contract Manufacturing Product Offered
Table 77. Samsung Biologics Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Samsung Biologics Main Business
Table 79. Samsung Biologics Latest Developments
Table 80. WuXi Biologics Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 81. WuXi Biologics Biosimilar Contract Manufacturing Product Offered
Table 82. WuXi Biologics Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. WuXi Biologics Main Business
Table 84. WuXi Biologics Latest Developments
Table 85. Element MaterialsTechnology Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 86. Element MaterialsTechnology Biosimilar Contract Manufacturing Product Offered
Table 87. Element MaterialsTechnology Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Element MaterialsTechnology Main Business
Table 89. Element MaterialsTechnology Latest Developments
Table 90. Rentschler Biopharma SE Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 91. Rentschler Biopharma SE Biosimilar Contract Manufacturing Product Offered
Table 92. Rentschler Biopharma SE Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Rentschler Biopharma SE Main Business
Table 94. Rentschler Biopharma SE Latest Developments
Table 95. Avid Bioservices, Inc. Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 96. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Product Offered
Table 97. Avid Bioservices, Inc. Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Avid Bioservices, Inc. Main Business
Table 99. Avid Bioservices, Inc. Latest Developments
Table 100. Alcami Corporation, Inc. Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 101. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Product Offered
Table 102. Alcami Corporation, Inc. Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Alcami Corporation, Inc. Main Business
Table 104. Alcami Corporation, Inc. Latest Developments
Table 105.Fujifilm Kyowa Kirin Biologics Co., Ltd. Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 106.Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Product Offered
Table 107.Fujifilm Kyowa Kirin Biologics Co., Ltd. Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108.Fujifilm Kyowa Kirin Biologics Co., Ltd. Main Business
Table 109.Fujifilm Kyowa Kirin Biologics Co., Ltd. Latest Developments
Table 110.ThermoFisher Scientific Inc. Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 111.ThermoFisher Scientific Inc. Biosimilar Contract Manufacturing Product Offered
Table 112.ThermoFisher Scientific Inc. Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113.ThermoFisher Scientific Inc. Main Business
Table 114.ThermoFisher Scientific Inc. Latest Developments
Table 115. Almac Group Details, CompanyType, Biosimilar Contract Manufacturing Area Served and Its Competitors
Table 116. Almac Group Biosimilar Contract Manufacturing Product Offered
Table 117. Almac Group Biosimilar Contract Manufacturing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Almac Group Main Business
Table 119. Almac Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Biosimilar Contract Manufacturing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilar Contract Manufacturing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Biosimilar Contract Manufacturing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Biosimilar Contract Manufacturing Sales Market Share by Country/Region (2024)
Figure 8. Biosimilar Contract Manufacturing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Biosimilar Contract Manufacturing Market Size Market Share byType in 2024
Figure 10. Biosimilar Contract Manufacturing in Oncology
Figure 11. Global Biosimilar Contract Manufacturing Market: Oncology (2020-2025) & ($ millions)
Figure 12. Biosimilar Contract Manufacturing in Blood Disorders
Figure 13. Global Biosimilar Contract Manufacturing Market: Blood Disorders (2020-2025) & ($ millions)
Figure 14. Biosimilar Contract Manufacturing in Growth Hormonal Deficiency
Figure 15. Global Biosimilar Contract Manufacturing Market: Growth Hormonal Deficiency (2020-2025) & ($ millions)
Figure 16. Biosimilar Contract Manufacturing in Chronic & Autoimmune Disorders
Figure 17. Global Biosimilar Contract Manufacturing Market: Chronic & Autoimmune Disorders (2020-2025) & ($ millions)
Figure 18. Biosimilar Contract Manufacturing in Rheumatoid Arthritis
Figure 19. Global Biosimilar Contract Manufacturing Market: Rheumatoid Arthritis (2020-2025) & ($ millions)
Figure 20. Biosimilar Contract Manufacturing in Others
Figure 21. Global Biosimilar Contract Manufacturing Market: Others (2020-2025) & ($ millions)
Figure 22. Global Biosimilar Contract Manufacturing Market Size Market Share by Application in 2024
Figure 23. Global Biosimilar Contract Manufacturing Revenue Market Share by Player in 2024
Figure 24. Global Biosimilar Contract Manufacturing Market Size Market Share by Region (2020-2025)
Figure 25. Americas Biosimilar Contract Manufacturing Market Size 2020-2025 ($ millions)
Figure 26. APAC Biosimilar Contract Manufacturing Market Size 2020-2025 ($ millions)
Figure 27. Europe Biosimilar Contract Manufacturing Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Biosimilar Contract Manufacturing Market Size 2020-2025 ($ millions)
Figure 29. Americas Biosimilar Contract Manufacturing Value Market Share by Country in 2024
Figure 30. United States Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Biosimilar Contract Manufacturing Market Size Market Share by Region in 2024
Figure 35. APAC Biosimilar Contract Manufacturing Market Size Market Share byType (2020-2025)
Figure 36. APAC Biosimilar Contract Manufacturing Market Size Market Share by Application (2020-2025)
Figure 37. China Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 41. India Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Biosimilar Contract Manufacturing Market Size Market Share by Country in 2024
Figure 44. Europe Biosimilar Contract Manufacturing Market Size Market Share byType (2020-2025)
Figure 45. Europe Biosimilar Contract Manufacturing Market Size Market Share by Application (2020-2025)
Figure 46. Germany Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 47.France Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Biosimilar Contract Manufacturing Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Biosimilar Contract Manufacturing Market Size Market Share byType (2020-2025)
Figure 53. Middle East & Africa Biosimilar Contract Manufacturing Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 57.Turkey Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Biosimilar Contract Manufacturing Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 60. APAC Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 61. Europe Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 63. United States Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 64. Canada Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 65. Mexico Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 66. Brazil Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 67. China Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 68. Japan Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 69. Korea Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 71. India Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 72. Australia Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 73. Germany Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 74.France Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 75. UK Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 76. Italy Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 77. Russia Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 78. Egypt Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 79. South Africa Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 80. Israel Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 81.Turkey Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)
Figure 82. Global Biosimilar Contract Manufacturing Market Size Market ShareForecast byType (2026-2031)
Figure 83. Global Biosimilar Contract Manufacturing Market Size Market ShareForecast by Application (2026-2031)
Figure 84. GCC Countries Biosimilar Contract Manufacturing Market Size 2026-2031 ($ millions)